CNO Financial Group (CNO) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

CNO Financial Group

NYSE•Financial Services•Insurance - Life

$55.55-0.17(<0.01%)Pre-market

Market Cap

$5.15B

P/E

17.9x

P/S

1.1x

P/B

2.0x

CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance and other insurance products, and financial services for middle-income pre-retiree and retired Americans in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individual consumers through phone, virtually, online, and face-to-face with agents. The company also focuses on sale of voluntary benefit life and health insurance products for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed indexed annuities; fixed interest annuities, including fixed rate single-premium deferred annuities; flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees, lesser degree, and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. It markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company was founded in 1979 and is headquartered in Carmel, Indiana.

How this company scores

AverageMetricSide Score: 57/100

Strongest: Cash & Earnings Quality (18/25); weakest: Balance Sheet & Red Flags (10/25).

Profitability13/25

Growth16/25

Balance Sheet & Red Flags10/25

Cash & Earnings Quality18/25

Strengths

Cash-backed earningsConsistent free cash flowNet cash positionNo share dilution

No red flags in the last 8 quarters.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 17.9x5y range 4.4x – 17.9x

Currently above its 20-quarter median.

P/S · 1.1x5y range 0.6x – 1.1x

Currently above its 20-quarter median.

P/B · 2.0x5y range 0.6x – 2.0x

Price & Volume

Market Cap $5.15B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $4.65B
Q. Revenue: $1.29B
TTM EBITDA: $1.11B
TTM Op. Income: $617.20M
Q. Op. Income: $151.00M
TTM Net Income: $287.40M
Q. Net Income: $125.90M
EPS: $1.35
Shares Out.: $93.19M

$4.65B in TTM revenue grew 6.0% YoY, reaching $1.29B last quarter. TTM EBITDA of $1.11B and TTM operating income of $617.20M show growth is flowing through to the bottom line. TTM net income of $287.40M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 5 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: 18.3%
Op. Margin: 11.7%
Net Margin: 9.8%

Op. margin of 11.7% is up 2.0% YoY — cost efficiency is improving. Net margin at 9.8% Across the last 8 quarters, operating margin has fallen for 2 consecutive quarters — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 17.9x
P/S Ratio: 1.1x
P/B Ratio: 2.0x

At 17.9x P/E, the stock trades within typical market levels. P/S of 1.1x and P/B of 2.0x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is up 32% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $39.86B
Cash: $1.31B
Long-Term Debt: N/A
Book Value: $2.59B
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $156.60M
TTM Free Cash Flow: $698.90M
FCF Margin: 15.0%
FCF / Net Income: 2.4

TTM FCF of $698.90M on $156.60M in operating cash flow. The FCF / Net Income ratio of 2.4x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 3 consecutive quarters — an improving trend.